Evaluating the diagnostic performance of 18F-fluciclovine for detection of recurrent brain metastases after radiation therapy: Results from a prospective phase 2 trial. 2023

Research output: Contribution to conferencePresentation

Original languageAmerican English
StatePublished - Jun 2 2023

Cite this